Testing effectiveness (Phase 2)UnknownNCT01267578What this trial is testingPeptide Vaccination in Treating Patients With Esophageal Cancer (STF-II)Who this might be right forEsophageal Cancer University of Yamanashi 60
Early research (Phase 1)Looking for participantsNCT07519655What this trial is testingPhase 1 Study of PF-08046033 in Advanced Solid TumorsWho this might be right forNon-Small-Cell LungEsophageal CancerCutaneous Melanoma Pfizer 250
Testing effectiveness (Phase 2)Looking for participantsNCT06410651What this trial is testingNimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal CancerNimotuzumabChemoradiotherapy+2 more Cancer Institute and Hospital, Chinese Academy of Medical Sciences 53
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06965829What this trial is testingThe Effect of Neoadjuvant Chemoimmnotherapy Combined With Node Sparing Radiotherapy for cT3N+ ECWho this might be right forEsophageal Cancer Stage III Shanghai Chest Hospital 40
Early research (Phase 1)Looking for participantsNCT07277413What this trial is testingIDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid TumorsWho this might be right forNSCLC AdenocarcinomaGastroesophageal Cancer (GC)Gastric Adenocarcinoma+10 more IDEAYA Biosciences 260
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06814158What this trial is testingNeoadjuvant Ivonescimab and Chemotherapy in Resectable Esophageal CancerWho this might be right forEsophageal Squamour Cell Cancer Tianjin Medical University Cancer Institute and Hospital 57
Not applicableStudy completedNCT04028479What this trial is testingThe Registry of Oncology Outcomes Associated With Testing and TreatmentWho this might be right forAdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more Taproot Health 167
Not applicableNot Yet RecruitingNCT04616040What this trial is testingA Real-world Study Evaluating the Usage of Camrelizumab in Chinese Patients With Advanced Esophageal CancerWho this might be right forEsophageal Cancer Peking University 1,030
Large-scale testing (Phase 3)Ended earlyNCT01704690What this trial is testingCombination Treatment of S-1 With Paclitaxel in Advanced Esophageal CancerWho this might be right forEsophageal Cancer Peking University 4
Early research (Phase 1)Study completedNCT00019435What this trial is testingLMB-9 Immunotoxin in Treating Patients With Advanced Solid TumorsWho this might be right forBladder CancerBreast CancerColorectal Cancer+4 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT02489201What this trial is testingDonafenib Monotherapy in Advanced Oesophageal CancerWho this might be right forOesophageal Cancer Suzhou Zelgen Biopharmaceuticals Co.,Ltd 19
Not applicableNot Yet RecruitingNCT07533357What this trial is testingTpex Subsets in Negative Tumor Draining Lymph Nodes for Predicting the Efficacy of PD 1 Inhibitors in Advanced or Recurrent Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Cancer Fudan University 158
Testing effectiveness (Phase 2)Looking for participantsNCT06780111What this trial is testingSubstudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)Who this might be right forEsophageal Squamous Cell Carcinoma Merck Sharp & Dohme LLC 298
Testing effectiveness (Phase 2)Study completedNCT01443065What this trial is testingMEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal AdenocarcinomaWho this might be right forMalignant Neoplasm of EsophagusMalignant Neoplasm of Stomach UNICANCER 162
Testing effectiveness (Phase 2)Study completedNCT00003137What this trial is testingIrinotecan in Treating Patients With Advanced Cancer of the StomachWho this might be right forEsophageal CancerGastric Cancer Alliance for Clinical Trials in Oncology 70
Testing effectiveness (Phase 2)Study completedNCT02607982What this trial is testingCCRT for Esophageal Cancer.Who this might be right forEsophageal CancerConcurrent ChemoradiotherapyOxaliplatin+1 more Hangzhou Cancer Hospital 34
Not applicableUnknownNCT05615103What this trial is testingThe PET-CT Predicting Response to Immunochemotherapy in Esophageal CancerWho this might be right forEsophageal Cancer Guangdong Provincial People's Hospital 100
Testing effectiveness (Phase 2)WithdrawnNCT02034968What this trial is testingNimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal CarcinomaWho this might be right forStage IV Esophageal Squamous Cell Carcinoma Zhejiang University
Testing effectiveness (Phase 2)Study completedNCT02861690What this trial is testingLiposomal Paclitaxel Combined Nedaplatin in Treatment of Advanced or Recurrent Esophageal CarcinomaWho this might be right forEsophageal Carcinoma Sun Yat-sen University 72
Testing effectiveness (Phase 2)UnknownNCT05013697What this trial is testingTQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer.Who this might be right forEsophageal Neoplasms Henan Cancer Hospital 48